Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB01072_nanopub.RA1yNJ0UcYPfqcnRcEpFdrB0nz6iSNE6oJfndHMgZ98Ks#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB01072 label "DDI between Trazodone and Atazanavir - The protease inhibitor, Atazanavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Atazanavir is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB01072]" assertion.
- drugbank_resource:DB00656_DB01072 identifier "drugbank_resource:DB00656_DB01072" assertion.
- drugbank_resource:DB00656_DB01072 title "DDI between Trazodone and Atazanavir - The protease inhibitor, Atazanavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Atazanavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01072 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01072 assertion.